Displaying 401 - 420 of 1600
Statement of the Federal Trade Commission in the matter of Roche Holding/Spark Therapeutics
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Rohit Chopra, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
191 0086
Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.
Date
The Federal Trade Commission has closed its investigation into Roche Holding AG’s proposed acquisition of Spark Therapeutics, Inc. According to a Commission Statement, after an exhaustive, 10-month...
FTC Comment to Texas Medical Board Raises Competitive Concerns about Proposed Rule Imposing Additional Supervisory Requirements on Texas-Certified Nurse Anesthetists
Date
The Federal Trade Commission staff has submitted a comment to the Texas Medical Board raising concerns that the board’s Proposed Rule § 193.13 could harm competition by impeding access to surgical and...
FTC Submits Comment in Favor of Amendments to North Carolina’s Administrative Code that would Promote Expanded Access to Preventive Dental Services
Date
The Federal Trade Commission staff has submitted a comment to the North Carolina State Board of Dental Examiners expressing support for proposed changes to the North Carolina Administrative Code that...
FTC Staff Comment to the North Carolina State Board of Dental Examiners Regarding Proposed Rule Changes to 21 N.C. Admin. Code 16W
Date
Matter Number
V200003
File
Text of the Staff Comment
(178.29 KB)
Statement of Commissioner Noah Joshua Phillips In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Noah Joshua Phillips, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
Dissenting Statement of Commissioner Rohit Chopra In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Rohit Chopra, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
Statement of Commissioner Christine S. Wilson In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
File
FTC Submits Comment in Favor of Massachusetts House Bill 1869, which would Expand Scope of Practice for Podiatrists
Date
The Federal Trade Commission staff has submitted a comment to Massachusetts State Representative Paul Donato in support of a bill before the Massachusetts legislature, which would allow podiatrists to...
Comment of the Staff of the Federal Trade Commission to Massachusetts Rep. Paul J. Donato regarding HB1869 and SB1329
Date
Matter Number
V2000002
File
Text of the FTC Staff Comment
(10.91 MB)
Dental Products Distributors Benco Dental Supply Company, Patterson Companies, Inc. Decline to Appeal ALJ Decision, Making that Decision Final
Date
After Chief Administrative Law Judge D. Michael Chappell held in his Initial Decision that two of three respondents named in a Federal Trade Commission complaint violated U.S. antitrust laws, those...
FTC Commissioners Unanimously Find that Consummated Merger of Microprocessor Prosthetic Knee Companies Was Anticompetitive; Assets Must Be Unwound
Date
The Federal Trade Commission issued an Opinion and Final Order in which the Commission upholds the Administrative Law Judge’s decision that the consummated acquisition of Freedom Innovations by Otto...
Statement of Federal Trade Commission In the Matter of Your Therapy Source, Neeraj Jindal and Sheri Yarbray
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
FTC Approves Final Order Prohibiting Conduct by Therapist Staffing Company and Two Owners Accused of Colluding with Competitors on Compensation
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that a Texas company providing therapist staffing services to home health agencies, its...
FTC Sends Warning Letters to Sellers of Cosmetic Contacts: All Contact Lens Purchases Require a Prescription from a Medical Professional
Date
As Halloween approaches and consumers consider temporarily changing their eye color or the look of their eyes to match their costumes, Federal Trade Commission staff has sent letters to seven domestic...
FTC Amicus Brief Explains that Relevant Antitrust Markets Should be Defined in Light of the Anticompetitive Effects Alleged
Date
The Federal Trade Commission has submitted an amicus brief concerning market definition in Staley v Gilead Sciences Inc., an antitrust case pending before the U.S. District Court for the Northern...
Displaying 401 - 420 of 1600